Bioavailability of Experimental and Prototype Tablets in HV(QBR115387)

• Research type

  Research Study

• Full title

  A Randomized Open-Label Cross Over Study of the Bioavailability of a Prototype and Experimental Fixed Dose Combination Formulations of Asunaprevir, Daclatasvir and BMS-791325 Relative to the Co-administration of the Single Agent Reference Tablets in Healthy Subjects

• IRAS ID

  127690

• Contact name

  Philip Evans

• Contact email

  Phil.Evans@quotientclinical.com

• Sponsor organisation

  Bristol-Myers Squibb Research and Development

• Eudract number

  2013-000627-13

• ISRCTN Number

  to be registered

• REC name

  Wales REC 1

• REC reference

  13/WA/0102

• Date of REC Opinion

  14 Apr 2013

• REC opinion

  Favourable Opinion